Molecular targeting of the oncogene eIF4E in acute myeloid leukemia (AML): a proof-of-principle clinical trial with ribavirin

Authors

Keywords

Journal

Volume 114, Issue 2, Pages 257-260

Publisher

American Society of Hematology

Online

2009-05-12

DOI

10.1182/blood-2009-02-205153

References

View 4 related references

Explore over 38,000 international journals covering a vast array of academic fields.

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now